The April 2025 Presidential Executive Order, “Lowering Drug Prices by Once Again Putting Americans First,” brings forth a restructuring of the regulatory landscape for pharmaceutical and healthcare entities. These organizations are urgently analyzing current contracts and generating new agreements to comply with impending federal reforms aimed at reducing medication costs. In the heat of this scramble, powerful pharma contract management and healthcare agreement software solutions have gone from optional resources to essential assets for legal and procurement teams.
To that end, let's examine how integrated pharma contract management, healthcare agreement, and hospital procurement software solutions can help organizations easily navigate new drug pricing reforms.